.png?w=1920&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=F7EB8E87200F93D9631B5AA244BF29D1)
Are you attending AAPS PharmaSci 360?
AAPS PharmSci 360 is known as the “home for pharmaceutical scientists” where attendees network across the entire drug development and delivery continuum, end to end.
Croda Pharma and Avanti Research will be highlighting our Small Molecule Delivery solutions, ranging from Super Refined™ high purity excipients through to our expertise in lipid formulation.
Where you can find us:
When: November 9-12, 2025
Where: Henry B. Gonzalez Convention Center, San Antonio, TX
Booth location: 3442
Join our mailing list...
Get exclusive access to our newest excipients and hear direct from the experts on how to improve your formulations.
High Purity Excipients and Lipids in Enabling Advanced Drug Delivery
Visit our talk on Tuesday November 11 at 10:30am, 360 Stage #3, Exhibition Hall
This presentation examines the impact of excipient purity on formulation performance across small molecules, proteins, and nucleic acids. A high-purity dimethyl isosorbide enhances dermal permeation with improved stability in topical small molecule systems. Case studies reveal the role of polysorbate in mitigating surface-induced protein destabilization, and the advantage of high purity surfactants in improving drug stability. Purified surfactants also stabilize RNA-loaded lipid nanoparticles against physical stress by preventing particle leakage and aggregation.
Objectives:
- Understand how excipient purity influences stability along with permeation and bioavailability in topical drug delivery.
- Investigate the impact of surfactant purity on formulation stability and strategies to mitigate enzymatic degradation
- Assess the role of purified surfactants in stabilizing LNP formulations for nucleic acid delivery upon mechanical shaking and freeze-thawing.
.png?la=en-gb&hash=862E70488F230C3E0925F941285156C5)
Event type: Exhibition
2025 AAPS PharmSci 360
AAPS PharmSci 360 is a comprehensive pharmaceutical sciences event covering discovery and basic research, preclinical, clinical, and translational sciences, bioanalytics, manufacturing and analytical characterization, and drug formulation as well as delivery. This summit also explores innovative approaches, emerging technologies, regulatory guidance for AI/ML, and advancements in pharmaceutical and biopharmaceutical development, including novel modalities and patient-centric delivery strategies. Include us in your conference plans and book your meeting today!
How we empower biologics delivery
